Steven Cohen’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Other funds holding DNTH
Steven Cohen's DNTH Position: Q3 2026 in Review
Steven Cohen opened a new position in Dianthus Therapeutics (DNTH) in Q3 2026: 290,622 shares worth $25.6M. The stake represents 0.03% of the portfolio and ranks #775 among its holdings. This is a return to the name: Steven Cohen previously reported a position in DNTH as recently as Q1 2026.
Steven Cohen first reported a position in DNTH in Q2 2018 and has held it in 11 quarters since. The position peaked at $80.4M in Q3 2025. 273 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.
- Steven Cohen held 290,622 shares of Dianthus Therapeutics worth $25.6M as of Q3 2026.
- Dianthus Therapeutics was a new Steven Cohen position in Q3 2026.
- Dianthus Therapeutics made up 0.03% of Steven Cohen's portfolio in Q3 2026, its #775 holding.
- Steven Cohen first reported a position in Dianthus Therapeutics in Q2 2018 and has held it in 11 quarters since.
- Steven Cohen's Dianthus Therapeutics position peaked at $80.4M in Q3 2025.
- 273 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.